Literature DB >> 35244676

Sex-related association of nonalcoholic fatty liver disease and liver fibrosis with body fat distribution in the general US population.

Stefano Ciardullo1,2, Alice Oltolini1, Rosa Cannistraci1,2, Emanuele Muraca1, Gianluca Perseghin1,2.   

Abstract

BACKGROUND: Few population-based studies have investigated the association between body fat distribution and the risk of nonalcoholic fatty liver disease (NAFLD) and significant liver fibrosis.
OBJECTIVES: We aimed to evaluate the relations of total body fat and body fat distribution with NAFLD in the general US population.
METHODS: This is a cross-sectional, population-based study based on the 2017-2018 cycle of the NHANES. Participants aged 18-59 y without known liver conditions or significant alcohol consumption were studied by DXA and vibration-controlled transient elastography to assess body composition and liver steatosis and fibrosis, respectively. Multivariable logistic regression analysis was performed to evaluate the contribution of BMI and android:gynoid ratio (A:G ratio) to the prevalence of liver steatosis and fibrosis in males and females.
RESULTS: Weighted prevalence of steatosis was 41.5% and 29.9% among the 1115 males and 1113 females included in the study, respectively, whereas 7.0% of males and 4.0% of females had elastographic evidence of significant liver fibrosis. After adjustment for age, race-Hispanic origin, diabetes, cigarette smoke, and BMI, a higher A:G ratio was associated with increased odds of steatosis in both males (OR: 1.79; 95% CI: 1.07, 2.99; P = 0.029) and females (OR: 1.95; 95% CI: 1.11, 3.41; P = 0.023). Conversely, a significant association between A:G ratio and liver fibrosis was identified in females (OR: 2.09; 95% CI: 1.11, 3.97; P = 0.026), but not in males (OR: 0.56; 95% CI: 0.29, 1.08; P = 0.078).
CONCLUSIONS: Independently from BMI, an android fat deposition pattern is associated with increased prevalence of NAFLD in both sexes, whereas the effect on fibrosis was only evident in females.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  DXA; MAFLD; NAFLD; android; visceral adipose tissue

Mesh:

Year:  2022        PMID: 35244676     DOI: 10.1093/ajcn/nqac059

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   8.472


  3 in total

1.  Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis.

Authors:  Karn Wijarnpreecha; Aijaz Ahmed; Donghee Kim
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

2.  Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease.

Authors:  Wen Guo; Xin Zhao; Mengyuan Miao; Xiuru Liang; Xiaona Li; Pei Qin; Jing Lu; Wenfang Zhu; Juan Wu; Chen Zhu; Nianzhen Xu; Qun Zhang
Journal:  Front Nutr       Date:  2022-04-26

3.  Association between the atherogenic index of plasma and new-onset non-alcoholic fatty liver disease in non-obese participants.

Authors:  Kemin Li; Ji Li; Xiaoyun Cheng; Jing Wang; Jingnan Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.